ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...

Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.

Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...

For a rugby legend like Rocky Elsom, the roar of the crowd has been replaced by the deafening silence of legal limbo.

FDA approvals, trial progress and early commercial momentum put several ASX healthcare companies in a strong position heading ...

Moderna (NasdaqGS:MRNA) is shifting away from self-funding new Phase III vaccine trials in response to increased vaccine hesitancy in the U.S. The company is seeking external partners to finance and ...

Protect your Most Important Assets: Your Personal Information. GET your 14-Day FREE TRIAL following my link with AURA at NEW!

CalciMedica ( (CALC) ) has shared an announcement.

Significant progress across its clinical pipeline and a robust balance sheet are positioning 4D Molecular Therapeutics for a ...

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.

We continue to focus on delivering meaningful impact for patients and long-term value for our shareholders.” Altimmune ...

Acumen Pharmaceuticals (ABOS) recently dosed the first participant in the open-label extension of its Phase 2 ALTITUDE-AD trial for sabirnetug, and also shared new Alzheimer’s research findings and ...